Skip to main content
Erschienen in: European Journal of Applied Physiology 3/2012

01.03.2012 | Original Article

Muscle ceramide content is similar after 3 weeks’ consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes

verfasst von: J. W. Helge, L. Tobin, T. Drachmann, L. I. Hellgren, F. Dela, H. Galbo

Erschienen in: European Journal of Applied Physiology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

This study aimed at investigating the effect of prolonged adaptation to fat- or carbohydrate-rich diet on muscle ceramide in type 2 diabetes patients, using a longitudinal crossover study. Eleven type 2 diabetes patients consumed isocaloric fat- or carbohydrate-rich diet for 3 weeks in random order. After each dietary intervention period, muscle glycogen, triacylglycerol and ceramide content and plasma concentrations of insulin, adiponectin, glucose and FFA were determined. Insulin resistance was assessed by HOMA2 calculation. After the dietary period, plasma glucose and insulin, insulin sensitivity, muscle glycogen, triacylglycerol and ceramide content were similar. Plasma adiponectin concentration was significantly higher after fat compared with carbohydrate-rich diet. Results indicated that following fat-rich diet intake muscle ceramide and triacylglycerol concentrations were not different compared with that after carbohydrate-rich diet. Furthermore, plasma adiponectin concentration was higher after fat-rich compared with carbohydrate-rich diet, but insulin sensitivity remained similar despite the major difference in dietary macronutrient composition.
Literatur
Zurück zum Zitat Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53(1):25–31PubMedCrossRef Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53(1):25–31PubMedCrossRef
Zurück zum Zitat Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936–942PubMed Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936–942PubMed
Zurück zum Zitat Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F, Meijer AJ, Sauerwein HP, Romijn JA (2001) Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 73(3):554–559PubMed Bisschop PH, de Metz J, Ackermans MT, Endert E, Pijl H, Kuipers F, Meijer AJ, Sauerwein HP, Romijn JA (2001) Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 73(3):554–559PubMed
Zurück zum Zitat Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46(1):3–10PubMedCrossRef Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46(1):3–10PubMedCrossRef
Zurück zum Zitat Bodennec J, Koul O, Aguado I, Brichon G, Zwingelstein G, Portoukalian J (2000) A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J Lipid Res 41(9):1524–1531PubMed Bodennec J, Koul O, Aguado I, Brichon G, Zwingelstein G, Portoukalian J (2000) A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J Lipid Res 41(9):1524–1531PubMed
Zurück zum Zitat Bose R, Chen P, Loconti A, Grullich C, Abrams JM, Kolesnick RN (1998) Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem 273(44):28852–28859PubMedCrossRef Bose R, Chen P, Loconti A, Grullich C, Abrams JM, Kolesnick RN (1998) Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem 273(44):28852–28859PubMedCrossRef
Zurück zum Zitat Bruce CR, Mertz VA, Heigenhauser GJ, Dyck DJ (2005) The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54(11):3154–3160PubMedCrossRef Bruce CR, Mertz VA, Heigenhauser GJ, Dyck DJ (2005) The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54(11):3154–3160PubMedCrossRef
Zurück zum Zitat Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O’brien PE, Dixon JB, Cameron-Smith D, Kemp BE, Steinberg GR (2005) Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90(6):3665–3672PubMedCrossRef Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O’brien PE, Dixon JB, Cameron-Smith D, Kemp BE, Steinberg GR (2005) Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90(6):3665–3672PubMedCrossRef
Zurück zum Zitat Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, Mandarino L, Ravussin E, Smith SR (2006) Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4(1):75–87PubMedCrossRef Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, Mandarino L, Ravussin E, Smith SR (2006) Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4(1):75–87PubMedCrossRef
Zurück zum Zitat Coen PM, Dube JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, Goodpaster BH (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59(1):80–88PubMedCrossRef Coen PM, Dube JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, Goodpaster BH (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59(1):80–88PubMedCrossRef
Zurück zum Zitat Cutler DL, Gray CG, Park SW, Hickman MG, Bell JM, Kolterman G (1995) Low-carbohydrate diet alters intracellular glucose metabolism but not overall glucose disposal in exercise-trained subjects. Metabolism 44:1264–1270PubMedCrossRef Cutler DL, Gray CG, Park SW, Hickman MG, Bell JM, Kolterman G (1995) Low-carbohydrate diet alters intracellular glucose metabolism but not overall glucose disposal in exercise-trained subjects. Metabolism 44:1264–1270PubMedCrossRef
Zurück zum Zitat Drachmann T, Mathiassen JH, Pedersen MH, Hellgren LI (2007) The source of dietary fatty acids alter the activity of secretory sphingomyelinase in the rat. Eur J Lipid Sci Technol 109:103–109CrossRef Drachmann T, Mathiassen JH, Pedersen MH, Hellgren LI (2007) The source of dietary fatty acids alter the activity of secretory sphingomyelinase in the rat. Eur J Lipid Sci Technol 109:103–109CrossRef
Zurück zum Zitat Esposito K, Nappo F, Giugliano F, Di PC, Ciotola M, Barbieri M, Paolisso G, Giugliano D (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78(6):1135–1140PubMed Esposito K, Nappo F, Giugliano F, Di PC, Ciotola M, Barbieri M, Paolisso G, Giugliano D (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78(6):1135–1140PubMed
Zurück zum Zitat Feskens EJM, Kromhout D (1997) Habitual dietary intake and glucose tolerance in euglycemic men: the Zutphen study. Int J Epidemiol 19:953–959CrossRef Feskens EJM, Kromhout D (1997) Habitual dietary intake and glucose tolerance in euglycemic men: the Zutphen study. Int J Epidemiol 19:953–959CrossRef
Zurück zum Zitat Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK (2005) Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 117(2):152–160PubMedCrossRef Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK (2005) Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 117(2):152–160PubMedCrossRef
Zurück zum Zitat Garcia-Roves P, Huss JM, Han DH, Hancock CR, Iglesias-Gutierrez E, Chen M, Holloszy JO (2007) Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA 104(25):10709–10713PubMedCrossRef Garcia-Roves P, Huss JM, Han DH, Hancock CR, Iglesias-Gutierrez E, Chen M, Holloszy JO (2007) Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA 104(25):10709–10713PubMedCrossRef
Zurück zum Zitat Goodpaster BH, Kelley DE (2002) Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep 2(3):216–222PubMedCrossRef Goodpaster BH, Kelley DE (2002) Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep 2(3):216–222PubMedCrossRef
Zurück zum Zitat Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51(1):144–151PubMedCrossRef Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51(1):144–151PubMedCrossRef
Zurück zum Zitat Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO (2008) High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 105(22):7815–7820PubMedCrossRef Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO (2008) High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 105(22):7815–7820PubMedCrossRef
Zurück zum Zitat Helge JW (2002a) Long-term fat diet adaptation effects on performance, training capacity, and fat utilization. Med Sci Sports Exerc 34(9):1499–1504PubMedCrossRef Helge JW (2002a) Long-term fat diet adaptation effects on performance, training capacity, and fat utilization. Med Sci Sports Exerc 34(9):1499–1504PubMedCrossRef
Zurück zum Zitat Helge JW (2002b) Prolonged adaptation to fat-rich diet and training; effects on body fat stores and insulin resistance in man. Int J Obes Relat Metab Disord 26(8):1118–1124PubMedCrossRef Helge JW (2002b) Prolonged adaptation to fat-rich diet and training; effects on body fat stores and insulin resistance in man. Int J Obes Relat Metab Disord 26(8):1118–1124PubMedCrossRef
Zurück zum Zitat Helge JW, Watt P, Richter EA, Rennie MJ, Kiens B (2002) Partial restoration of dietary fat induced metabolic adaptations to training by seven days of carbohydrate diet. J Appl Physiol 93(5):1797–1805PubMed Helge JW, Watt P, Richter EA, Rennie MJ, Kiens B (2002) Partial restoration of dietary fat induced metabolic adaptations to training by seven days of carbohydrate diet. J Appl Physiol 93(5):1797–1805PubMed
Zurück zum Zitat Helge JW, Dobrzyn A, Saltin B, Gorski J (2004) Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp Physiol 89(1):119–127PubMedCrossRef Helge JW, Dobrzyn A, Saltin B, Gorski J (2004) Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp Physiol 89(1):119–127PubMedCrossRef
Zurück zum Zitat Helge JW, Stallknecht B, Drachmann T, Hellgren LI, Jimenez–Jimenez R, Andersen JL, Richelsen B, Bruun JM (2010) Improved glucose tolerance after intensive life style intervention occurs without changes in muscle ceramide or triacylglycerol in morbidly obese subjects. Acta Physiol (Oxf) 201(3):357–364. doi:10.1111/j.1748-1716.2010.02180.x CrossRef Helge JW, Stallknecht B, Drachmann T, Hellgren LI, Jimenez–Jimenez R, Andersen JL, Richelsen B, Bruun JM (2010) Improved glucose tolerance after intensive life style intervention occurs without changes in muscle ceramide or triacylglycerol in morbidly obese subjects. Acta Physiol (Oxf) 201(3):357–364. doi:10.​1111/​j.​1748-1716.​2010.​02180.​x CrossRef
Zurück zum Zitat Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, Wade MR, Tenorio VM, Kuo MS, Brozinick JT, Zhang BB, Birnbaum MJ, Summers SA, Scherer PE (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17(1):55–63PubMedCrossRef Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, Wade MR, Tenorio VM, Kuo MS, Brozinick JT, Zhang BB, Birnbaum MJ, Summers SA, Scherer PE (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17(1):55–63PubMedCrossRef
Zurück zum Zitat Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(7):2005–2011PubMedCrossRef Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(7):2005–2011PubMedCrossRef
Zurück zum Zitat Kiens B, Richter EA (1998) Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans. Am J Physiol Endocrinol 38(2):E332–E337 Kiens B, Richter EA (1998) Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans. Am J Physiol Endocrinol 38(2):E332–E337
Zurück zum Zitat Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12):2191–2192PubMedCrossRef Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12):2191–2192PubMedCrossRef
Zurück zum Zitat Marshall JA, Hoag S, Shetterly S, Hamman RF (1997) Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. Diabetes Care 17:50–56CrossRef Marshall JA, Hoag S, Shetterly S, Hamman RF (1997) Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. Diabetes Care 17:50–56CrossRef
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRef
Zurück zum Zitat McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51(1):7–18PubMedCrossRef McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51(1):7–18PubMedCrossRef
Zurück zum Zitat Merrill AH Jr., Wang E, Mullins RE, Jamison WC, Nimkar S, Liotta DC (1988) Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem 171(2):373–381PubMedCrossRef Merrill AH Jr., Wang E, Mullins RE, Jamison WC, Nimkar S, Liotta DC (1988) Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem 171(2):373–381PubMedCrossRef
Zurück zum Zitat Miles J, Glasscock R, Aikens J, Gerich J, Haymond M (1983) A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24(1):96–99PubMed Miles J, Glasscock R, Aikens J, Gerich J, Haymond M (1983) A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24(1):96–99PubMed
Zurück zum Zitat Moreno JA, Perez-Jimenez F, Marin C, Perez-Martinez P, Moreno R, Gomez P, Jimenez-Gomez Y, Paniagua JA, Lairon D, Lopez-Miranda J (2005) The apolipoprotein E gene promoter (-219G/T) polymorphism determines insulin sensitivity in response to dietary fat in healthy young adults. J Nutr 135(11):2535–2540PubMed Moreno JA, Perez-Jimenez F, Marin C, Perez-Martinez P, Moreno R, Gomez P, Jimenez-Gomez Y, Paniagua JA, Lairon D, Lopez-Miranda J (2005) The apolipoprotein E gene promoter (-219G/T) polymorphism determines insulin sensitivity in response to dietary fat in healthy young adults. J Nutr 135(11):2535–2540PubMed
Zurück zum Zitat Mortensen HB (1980) Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing. J Chromatogr 182(3–4):325–333PubMed Mortensen HB (1980) Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing. J Chromatogr 182(3–4):325–333PubMed
Zurück zum Zitat Mullen KL, Pritchard J, Ritchie I, Snook LA, Chabowski A, Bonen A, Wright D, Dyck DJ (2009) Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 296(2):R243–R251PubMedCrossRef Mullen KL, Pritchard J, Ritchie I, Snook LA, Chabowski A, Bonen A, Wright D, Dyck DJ (2009) Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 296(2):R243–R251PubMedCrossRef
Zurück zum Zitat Nordby P, Prats C, Kristensen D, Ekroos K, Forsberg G, Andersen JL, Ploug T, Dela F, Storlien L, Helge JW (2010) Muscle ceramide content in man is higher in type I than type II fibers and not influenced by glycogen content. Eur J Appl Physiol 109(5):935–943PubMedCrossRef Nordby P, Prats C, Kristensen D, Ekroos K, Forsberg G, Andersen JL, Ploug T, Dela F, Storlien L, Helge JW (2010) Muscle ceramide content in man is higher in type I than type II fibers and not influenced by glycogen content. Eur J Appl Physiol 109(5):935–943PubMedCrossRef
Zurück zum Zitat Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983–988PubMedCrossRef Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983–988PubMedCrossRef
Zurück zum Zitat Paniagua JA, de la Sacristana AG, Sanchez E, Romero I, Vidal-Puig A, Berral FJ, Escribano A, Moyano MJ, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2007) A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 26(5):434–444PubMed Paniagua JA, de la Sacristana AG, Sanchez E, Romero I, Vidal-Puig A, Berral FJ, Escribano A, Moyano MJ, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2007) A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 26(5):434–444PubMed
Zurück zum Zitat Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP (2007) Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 92(4):1524–1529PubMedCrossRef Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP (2007) Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 92(4):1524–1529PubMedCrossRef
Zurück zum Zitat Skovbro M, Baranowski M, Skov-Jensen C, Flint A, Dela F, Gorski J, Helge JW (2008) Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 51:1253–1261PubMedCrossRef Skovbro M, Baranowski M, Skov-Jensen C, Flint A, Dela F, Gorski J, Helge JW (2008) Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 51:1253–1261PubMedCrossRef
Zurück zum Zitat Smith AC, Mullen KL, Junkin KA, Nickerson J, Chabowski A, Bonen A, Dyck DJ (2007) Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol Endocrinol Metab 293(1):E172–E181PubMedCrossRef Smith AC, Mullen KL, Junkin KA, Nickerson J, Chabowski A, Bonen A, Dyck DJ (2007) Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol Endocrinol Metab 293(1):E172–E181PubMedCrossRef
Zurück zum Zitat Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Piotrowska M, Brzezinska Z, Gorski J (2004) Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 53(5):1215–1221PubMedCrossRef Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Piotrowska M, Brzezinska Z, Gorski J (2004) Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 53(5):1215–1221PubMedCrossRef
Zurück zum Zitat Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M (2007a) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50(11):2366–2373PubMedCrossRef Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M (2007a) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50(11):2366–2373PubMedCrossRef
Zurück zum Zitat Straczkowski M, Kowalska I, Nikolajuk A, Otziomek E, Adamska A, Karolczuk-Zarachowicz M, Gorska M (2007b) Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Int J Obes (Lond) 31(2):221–225CrossRef Straczkowski M, Kowalska I, Nikolajuk A, Otziomek E, Adamska A, Karolczuk-Zarachowicz M, Gorska M (2007b) Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Int J Obes (Lond) 31(2):221–225CrossRef
Zurück zum Zitat Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45(1):42–72PubMedCrossRef Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45(1):42–72PubMedCrossRef
Zurück zum Zitat Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang CC, Itani SI, Lodish HF, Ruderman NB (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99(25):16309–16313PubMedCrossRef Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang CC, Itani SI, Lodish HF, Ruderman NB (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99(25):16309–16313PubMedCrossRef
Zurück zum Zitat Vistisen B, Hellgren L, Vadset T, Scheede-Bergdahl C, Helge JW, Dela F, Stallknecht B (2008) Effect of gender on lipid-induced insulin resistance in obese subjects. Eur J Endocrinol 158(1):61–68PubMedCrossRef Vistisen B, Hellgren L, Vadset T, Scheede-Bergdahl C, Helge JW, Dela F, Stallknecht B (2008) Effect of gender on lipid-induced insulin resistance in obese subjects. Eur J Endocrinol 158(1):61–68PubMedCrossRef
Zurück zum Zitat Yost TJ, Jensen DR, Haugen BR, Eckel RH (1998) Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects. Am J Clin Nutr 68(2):296–302PubMed Yost TJ, Jensen DR, Haugen BR, Eckel RH (1998) Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects. Am J Clin Nutr 68(2):296–302PubMed
Metadaten
Titel
Muscle ceramide content is similar after 3 weeks’ consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes
verfasst von
J. W. Helge
L. Tobin
T. Drachmann
L. I. Hellgren
F. Dela
H. Galbo
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Applied Physiology / Ausgabe 3/2012
Print ISSN: 1439-6319
Elektronische ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-011-2041-x

Weitere Artikel der Ausgabe 3/2012

European Journal of Applied Physiology 3/2012 Zur Ausgabe